ICHOR Vascular is a platform clot removal system with FDA; 510(k) market clearance on our 7F & 14F Percutaneous Arterial & Venous Reperfusion Systems. We will also have our AV Access Reperfusion system cleared in Q1 2027. ICHOR is the future in treating vascular occlusions by offering a familiar and trusted mechanism of action with broad utility that drives adoption. The thrombectomy market is moving exactly where iCHOR is developing.